Study of Syncytin 2 in Normal and Down Syndrome-Affected Placenta
Author Information
Author(s): André Malassiné, Jean-Louis Frendo, Sandra Blaise, Karen Handschuh, Pascale Gerbaud, Vassilis Tsatsaris, Thierry Heidmann, Danièle Evain-Brion
Primary Institution: INSERM, U767, Université Paris Descartes, CNRS, Institut Gustave Roussy
Hypothesis
The study aims to investigate the expression and localization of syncytin 2 in human placenta at different stages of gestation, particularly in normal and trisomy 21-affected pregnancies.
Conclusion
Syncytin 2 expression highlights the abnormal trophoblast differentiation observed in placenta of fetal T21-affected pregnancies.
Supporting Evidence
- Syncytin 2 was found in cytotrophoblastic cells throughout normal pregnancy.
- In T21 placentas, syncytin 2 was mainly located in cuboidal cytotrophoblastic cells.
- Normal cytotrophoblastic cells fused and differentiated into syncytiotrophoblast, while T21 cells did not.
Takeaway
This study looks at a protein called syncytin 2 in the placenta, which helps cells stick together. It found that this protein behaves differently in normal pregnancies compared to those affected by Down syndrome.
Methodology
The study involved immunolocalization of syncytin 2 in placental tissues and in vitro culture of cytotrophoblastic cells from normal and T21-affected placentas.
Potential Biases
Potential bias may arise from the selection of placentas from specific conditions and the ethical considerations surrounding their collection.
Limitations
The study is limited by the small sample size and the specific focus on placentas from induced abortions and elective cesarean sections.
Participant Demographics
Placentas were collected from healthy mothers and those with T21-affected pregnancies, with a focus on second trimester samples.
Statistical Information
P-Value
p < 0.02
Statistical Significance
p < 0.02
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website